OpGen, Inc. (NasdaqCM:OPGN) says it may not be able to continue operating, with cash set to run out in September. The Rockville, Md.-based precision medicine company said Thursday it had explored options to improve its cash position since the end of the second quarter, but still concluded it may not be able to continue as a going concern. The company previously said its cash reserves would be sufficient to fund operations through September.

OpGen is still exploring alternatives, including restructuring, refinancing debt, seeking additional debt and selling assets, among others. OpGen said it also may secure relief under bankruptcy laws.